Sleep Apnea Syndrome clinical trials

Explore recruiting sleep apnea syndrome clinical trials.

Recruiting sleep apnea syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sleep Apnea Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double blind, placebo controlled, parallel, study to evaluate the effects of NAL in Obstructive Sleep Apnea Patients.

France, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

PILOT STUDY OF THE EFFECT OF A SUBSTANCE P ANTAGONIST, APREPITANT, ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND ARTERIAL HYPERTENSION SYNDROME - (APHOS3)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

SYNERGY OSA - EFFICACY, SAFETY and TOLERABILITY OF COMBINED THERAPY WITH A SOMNOMED ORAL APPLIANCE AND THE CARBONIC ANHYDRASE INHIBITOR SULTHIAME IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA. A Randomized, Double-Blind, Placebo Controlled, Proof-of-Concept Trial

Denmark, Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

ObStructive Sleep Apnoea ManageMent in Older AdUlts with Overweight or ObEsity: A Randomized ClinicaL Trial (SAMUEL study)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Temporal characterization of Extracellular Vesicles during cellular therapy using CAR-T cells and during the occurrence of Immune effector Cell-Associated Neurotoxicity Syndrome : the VESICANS study

France

Therapeutic use (Phase IV) EU CTIS Study details

Sleep Apnea Syndrome trials by city

Sleep Apnea Syndrome in Toronto Sleep Apnea Syndrome in Vancouver Sleep Apnea Syndrome in Montreal Sleep Apnea Syndrome in Calgary Sleep Apnea Syndrome in Edmonton Sleep Apnea Syndrome in Ottawa Sleep Apnea Syndrome in Winnipeg Sleep Apnea Syndrome in Quebec City Sleep Apnea Syndrome in Hamilton Sleep Apnea Syndrome in Kitchener Sleep Apnea Syndrome in London Sleep Apnea Syndrome in Halifax Sleep Apnea Syndrome in New York Sleep Apnea Syndrome in Los Angeles Sleep Apnea Syndrome in Chicago Sleep Apnea Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease